CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 159 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $9,831,000 | +48.8% | 627,000 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $6,609,000 | -58.2% | 627,000 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $15,813,000 | -9.5% | 627,000 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $17,474,000 | +147.4% | 627,000 | +62.0% | 0.01% | +150.0% |
| Q4 2014 | $7,063,000 | +40.8% | 387,000 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $5,016,000 | -20.6% | 387,000 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $6,316,000 | +24.6% | 387,000 | +34.8% | 0.00% | +100.0% |
| Q1 2014 | $5,071,000 | +4.7% | 287,000 | +43.5% | 0.00% | 0.0% |
| Q4 2013 | $4,842,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |